Medium ICSMA-18-142-01 2 CVEs

BD Kiestra and InoquIA Systems (Update A)

Published May 22, 2018 · Updated Oct 11, 2018 · Revision 2

Vendor: Becton, Dickinson and Company (BD) Product: BD Kiestra TLA WCA InoqulA+ speciman processor - Database (DB) Manager Product: BD Kiestra TLA WCA InoqulA+ speciman processor - PerformA Product: BD Kiestra TLA WCA InoqulA+ speciman processor - ReadA Overview Product: Database (DB) Manager Product: PerformA Product: ReadA Overview

Summary

Successful exploitation of these vulnerabilities may lead to loss or corruption of data.

Vulnerabilities 2

Unscored —

CVE-2018-10593

A vulnerability in DB Manager version 3.0.1.0 and previous and PerformA version 3.0.0.0 and previous allows an authoriz…

Becton, Dickinson and Company Kiestra and InoqulA systems

May 24, 2018
Unscored —

CVE-2018-10595

A vulnerability in ReadA version 1.1.0.2 and previous allows an authorized user with access to a privileged account on …

Becton, Dickinson and Company Kiestra and InoqulA systems

May 24, 2018

Revision history

2018-10-11 #2
ICSMA-18-142-01 BD Kiestra and InoquIA Systems (Update A)
2018-05-22 #1
ICSMA-18-142-01 BD Kiestra and InoquIA Systems

References

ICS Advisory ICSMA-18-142-01 Web Version
https://www.cisa.gov/news-events/ics-medical-advisories/icsma-18-142-01
Recommended Practices
https://www.cisa.gov/uscert/ics/alerts/ICS-ALERT-10-301-01
Recommended Practices
https://www.cisa.gov/news-events/ics-medical-advisories/icsma-18-142-01
Recommended Practices
https://www.cisa.gov/uscert/sites/default/files/recommended_practices/NCCIC_ICS-CERT_Defense_in_Depth_2016_S508C.pdf